Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Gilead Sciences, Inc. (NQ: GILD)
55.73 USD  -0.20 (-0.36%)
Streaming Delayed Price  /  Updated: 3:04 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Gilead Sciences, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report
Today 8:15 EDT
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
The Reason It Trades, What's Moving ELN, DELL, GILD and KEY
Today 4:00 EDT
from Marketwired News Releases
La Agencia Europea del Medicamento aprueba la solicitud de comercialización de sofosbuvir de Gilead para el tratamiento de la hepatitis C
May 22, 2013
from Business Wire Spanish
European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 21, 2013
from Business Wire News Releases
News Behind Insider Trading: American International Group, First Solar, Gilead Sciences, J.C. Penney, U.S. Bancorp, and Chesapeake Energy
May 21, 2013
from PR Newswire
Start Making Profits Now With AMAT, BMY, GILD and RENN
May 21, 2013
from Marketwired News Releases
Profitable Trading Secrets Revealed in GILD, NWSA, RF and MTG
May 18, 2013
from Marketwired News Releases
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 17, 2013
from Business Wire News Releases
Gilead anuncia datos de respuesta del estudio de Fase 2 de idelalisib para leucemia linfática crónica no tratada con anterioridad
May 16, 2013
from Business Wire Spanish
Strategy Behind Our Success, We Get in Early: GILD, MCP, GM and DF
May 16, 2013
from Marketwired News Releases
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
May 15, 2013
from Business Wire News Releases
In the Know, Smart Investing in FCX, GILD, AIG and BMY
May 15, 2013
from Marketwired News Releases
Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
May 14, 2013
from Business Wire News Releases
Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga
May 14, 2013
from PR Newswire
Special Situation Coming Soon, a Look Inside MS, GILD, FITB and WFR
May 14, 2013
from Marketwired News Releases
Secrets to Making Money in WCRX, T, GILD and IBM
May 11, 2013
from Marketwired News Releases
The Straight Truth, Investing in OXY, LULU, GILD and V
May 10, 2013
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: GILD, QCOM and DIS
May 07, 2013
from Marketwired News Releases
Trace Insider Trading in Intel, Pfizer, Gilead Sciences, General Electric, Exxon Mobil, and Walt Disney
May 07, 2013
from PR Newswire
Critical Alerts For Gilead, Schlumberger, Charles Schwab, Trulia, and Staples Released By InvestorsObserver
May 06, 2013
from PR Newswire
Earning Sneak Peek for American International Group, American Capital Agency, Cisco, General Electric, Intel, and Gilead Sciences
May 06, 2013
from PR Newswire
Key to Success, How to Profit: PM, WMT, GILD and SLB
May 03, 2013
from Marketwired News Releases
Gilead Sciences presenta resultados financieros correspondientes al primer trimestre de 2013
May 03, 2013
from Business Wire Spanish
Trader's Watch List - Gilead Sciences, Inc (NASDAQ:GILD), American International Group Inc (NYSE:AIG)
May 03, 2013
from SBWire Direct - Latest Press Releases
Gilead presenta datos provisionales del estudio de Fase 2 LONESTAR
May 03, 2013
from Business Wire Spanish
Gilead Sciences Announces First Quarter 2013 Financial Results
May 02, 2013
from Business Wire News Releases
Gilead Reports Interim Data From Phase 2 LONESTAR Study
May 02, 2013
from Business Wire News Releases
Special Offer for Shareholders of GILD, SLB, CVS and DIS
May 02, 2013
from Marketwired News Releases
The Real Story Behind GILD, ESRX and NUAN
May 01, 2013
from Marketwired News Releases
Gilead recibe cartas de respuesta completas de la Agencia de Alimentos y Fármacos (FDA) de Estados Unidos para elvitegravir y cobicistat
April 30, 2013
from Business Wire Spanish
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Random Thoughts: A Signal That Bears Watching
Todd Harrison
2
Random Thoughts: Can the S&P Trade to 1500?
Todd Harrison
3
Mother of All Fed Cha Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
4
Every Trader and Investor Should Be Watching the Dollar
Tom Pizzuti and Kurt Hulse
5
A Serious Drop in Japan's Stock Market Adds to Wall of Worry
Lloyd Khaner